Drug Profile
Research programme: hepatitis C virus NS3/4A protein inhibitors - Phenomix
Alternative Names: PHX-B; PHX-CLatest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator Phenomix Corporation
- Class Small molecules
- Mechanism of Action Hepatitis C virus NS3 protein inhibitors; Hepatitis C virus NS4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 14 Mar 2007 NS3/4A viral protease inhibitors are available for licensing worldwide (http://www.phenomixcorp.com)
- 13 Mar 2007 Preclinical trials in Hepatitis C treatment in USA (PO)